Drugmaker AstraZeneca announced some promising results from their phase 3 covid vaccine trial reporting their vaccine was 79% effective in preventing symptomatic covid and 100% effective in preventing..
Study Finds AstraZeneca Vaccine
to Be 79 Percent Efficient Against
Symptomatic COVID-19.
On Monday, results were announced from a late-stage
study on AstraZeneca’s COVID-19 vaccine, AZD1222...
Credit: Wibbitz Top Stories Duration: 01:11Published